Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IOVA

Iovance Biotherapeutics Inc

May 11 • 02:10PM ET

3.70

+0.08 2.21 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: LYEL ALLO AUTL SANA BEAM

| Held by: VTI XBI IWM VB VXF IWN VBR IBB VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.95	Insider Own	14.21%	Shs Outstand	438.11M	Perf Week	-3.90%
Market Cap	1.65B	Forward P/E	-	EPS next Y	-0.28	Insider Trans	0.00%	Shs Float	383.02M	Perf Month	0.00%
Enterprise Value	1.39B	PEG	-	EPS next Q	-0.13	Inst Own	54.74%	Short Float	28.41%	Perf Quarter	42.31%
Income	-353.86M	P/S	5.79	EPS this Y	50.45%	Inst Trans	13.71%	Short Ratio	6.55	Perf Half Y	60.17%
Sales	285.55M	P/B	2.25	EPS next Y	47.64%	ROA	-37.40%	Short Interest	108.80M	Perf YTD	35.53%
Book/sh	1.65	P/C	5.27	EPS next 5Y	-	ROE	-47.51%	52W High	5.63 -34.28%	Perf Year	111.43%
Cash/sh	0.70	P/FCF	-	EPS past 3/5Y	23.93% 10.23%	ROIC	-46.22%	52W Low	1.64 125.82%	Perf 3Y	-50.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	25.04%	Volatility	10.01% 7.64%	Perf 5Y	-86.04%
Dividend TTM	-	EV/Sales	4.86	EPS Y/Y TTM	23.00%	Oper. Margin	-125.41%	ATR (14)	0.29	Perf 10Y	-28.43%
Dividend Ex-Date	-	Quick Ratio	3.15	Sales Y/Y TTM	34.26%	Profit Margin	-123.92%	RSI (14)	51.60	Recom	1.64
Dividend Gr. 3/5Y	- -	Current Ratio	3.60	EPS Q/Q	47.50%	SMA20	1.76%	Beta	0.68	Target Price	8.80
Payout	-	Debt/Eq	0.07	Sales Q/Q	44.82%	SMA50	-2.70%	Rel Volume	1.08	Prev Close	3.62
Employees	975	LT Debt/Eq	0.06	Earnings	May 07 BMO	SMA200	32.85%	Avg Volume	16.61M	Price	3.70
IPO	Sep 01, 2009	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.70% -8.23%	Trades		Volume	13,120,954	Change	2.21%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)